Search hospitals > Oregon > Tualatin
Legacy Meridian Park Hospital
Claim this profileTualatin, Oregon 97062
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
152 reported clinical trials
7 medical researchers
Summary
Legacy Meridian Park Hospital is a medical facility located in Tualatin, Oregon. This center is recognized for care of Skin Cancer, Breast Cancer, Breast cancer, Lung Cancer, Stomach Cancer and other specialties. Legacy Meridian Park Hospital is involved with conducting 152 clinical trials across 280 conditions. There are 7 research doctors associated with this hospital, such as Andrew Y. Kee, Mei Dong, Colleen C. McCormick, and Jacqueline Vuky, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
ER positive
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Andrew Y. KeeLegacy Good Samaritan Hospital and Medical Center3 years of reported clinical research
Studies Brain Tumor
Studies Lung Cancer
19 reported clinical trials
60 drugs studied
Mei DongLegacy Good Samaritan Hospital and Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
15 reported clinical trials
39 drugs studied
Colleen C. McCormickLegacy Good Samaritan Hospital and Medical Center5 years of reported clinical research
Studies Ovarian Cancer
Studies Skin Cancer
13 reported clinical trials
44 drugs studied
Jacqueline Vuky, MDOregon Health and Science University8 years of reported clinical research
Studies Skin Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
24 drugs studied
Clinical Trials running at Legacy Meridian Park Hospital
Breast Cancer
Breast cancer
Lung Cancer
Ovarian Cancer
Skin Cancer
Prostate Cancer
Rectal Cancer
Non-Small Cell Lung Cancer
Uterine Cancer
Prostate Adenocarcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Legacy Meridian Park Hospital?
Legacy Meridian Park Hospital is a medical facility located in Tualatin, Oregon. This center is recognized for care of Skin Cancer, Breast Cancer, Breast cancer, Lung Cancer, Stomach Cancer and other specialties. Legacy Meridian Park Hospital is involved with conducting 152 clinical trials across 280 conditions. There are 7 research doctors associated with this hospital, such as Andrew Y. Kee, Mei Dong, Colleen C. McCormick, and Jacqueline Vuky, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.